Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2025)
Sol-Gel Technologies (SLGL) reported Long-Term Investments of $1.3 million for Q4 2025, up 2.56% year-over-year from $1.3 million in Q4 2024, and up 2.56% quarter-over-quarter from $1.3 million in Q4 2024.
Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2025) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of Long-Term Investments data on file, last reported at $1.3 million in Q4 2025.
- Long-Term Investments for Q4 2025 came in at $1.3 million, up 2.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 million (up 2.56% YoY), and the FY2025 annual result was $1.3 million, up 2.56% from the prior year.
- Long-Term Investments rose to $1.3 million in Q4 2025 per SLGL's latest filing, from $1.3 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $1.3 million in Q4 2025 and troughed at $12000.0 in Q2 2023.
- A 5-year average of $1.2 million and a median of $1.3 million in 2021 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2023 and 2025: Long-Term Investments plunged 99.07% in 2023, then advanced 2.56% in 2025.
- A 5-year view of Long-Term Investments shows it stood at $1.3 million in 2021, then dropped by 0.77% to $1.3 million in 2022, then retreated by 0.31% to $1.3 million in 2023, then rose by 0.55% to $1.3 million in 2024, then advanced by 2.56% to $1.3 million in 2025.
- Business Quant data shows SLGL's Long-Term Investments at $1.3 million in Q4 2025, $1.3 million in Q4 2024, and $1.3 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.29 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.30 Mn |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 1.29 Mn |
| Mar 31, 2021 | 1.29 Mn |
| Dec 31, 2020 | 1.29 Mn |
| Sep 30, 2020 | 1.29 Mn |
| Jun 30, 2020 | 1.28 Mn |
| Mar 31, 2020 | 1.27 Mn |
| Dec 31, 2019 | 472,000.00 |
| Sep 30, 2019 | 471,000.00 |